Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — August 2017

Planlagt Fastgjort Låst Flyttet Genmab
2.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • royalR Offline
    royalR Offline
    royal
    wrote on sidst redigeret af
    #14

    Hvordan kan kursen være 1,411.27 ?

    1 Reply Last reply
    0
    • H Offline
      H Offline
      Her_for_at_lære
      wrote on sidst redigeret af
      #15

      Er det AB der sælger ud af arvesølvet? 🙂

      1 Reply Last reply
      0
      • B Offline
        B Offline
        BiotechPro
        wrote on sidst redigeret af
        #16

        royal, det var en netbankhandel i Lån & Spar. En kunde har f.eks. købt/solgt 100 stk. fordelt på 73 stk. i 1411 og 27 stk. i 1412

        1 Reply Last reply
        0
        • royalR Offline
          royalR Offline
          royal
          wrote on sidst redigeret af
          #17

          Ok, tak, alligevel lidt underligt.

          1 Reply Last reply
          0
          • AH2005A Offline
            AH2005A Offline
            AH2005
            wrote on sidst redigeret af
            #18

            De skæve tal er forekommet før, har selv gjort opmærksom på det før.

            1 Reply Last reply
            0
            • B Offline
              B Offline
              BiotechPro
              wrote on sidst redigeret af
              #19

              Bryan Garnier om Zeal: Of course, Soliqua remains a meaningful part of the story in the short term and represents a risk of volatility since the numbers are unlikely to be meaningful until the end of 2017. But dasiglucagon and glepaglutide are increasingly heavy in the FV, which we see as very positive for the investment case. In less than 12 months, the group will have two molecules in phase III trials.

              1 Reply Last reply
              0
              • B Offline
                B Offline
                BiotechPro
                wrote on sidst redigeret af
                #20

                ups, skulle have været i bava/zeal debatten

                1 Reply Last reply
                0
                • R Offline
                  R Offline
                  rex_pacis
                  wrote on sidst redigeret af
                  #21

                  man kan vel altid byde/udbyde skæve beløb, og så se hvem som bider på, men underligt det var i GEN. Markedet er bare underligt nogen gange. Jeg kan dog ikke se den nævnte handel..

                  1 Reply Last reply
                  0
                  • B Offline
                    B Offline
                    BiotechPro
                    wrote on sidst redigeret af
                    #22

                    rex pacis, det var en kunde der handlede en ordre fordelt over to prisniveauer gennem sin netbank. Når banken så eksekverer ordren over børsen bliver det en skæv pris

                    1 Reply Last reply
                    0
                    • D Offline
                      D Offline
                      DevOp
                      wrote on sidst redigeret af
                      #23

                      tak Solsen - bliver interessant at se, om det vinder indpas og evt udvider markedsandelen for dara.

                      1 Reply Last reply
                      0
                      • DarvinD Offline
                        DarvinD Offline
                        Darvin
                        wrote on sidst redigeret af
                        #24

                        Nyt: https://clinicaltrials.gov/ct2/show/NCT03234972?term=A+Study+to+Compare+Daratumumab%2C+Bortezomib%2C+and+Dexamethasone+(DVd)+vs+Bortezomib+and+Dexamethasone+(Vd)+in+Chinese+Participants+With+Relapsed+or+Refractory+Multiple+Myeloma&rank=1

                        1 Reply Last reply
                        0
                        • H Offline
                          H Offline
                          Her_for_at_lære
                          wrote on sidst redigeret af
                          #25

                          God Morgen

                          1 Reply Last reply
                          0
                          • Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktør
                            wrote on sidst redigeret af
                            #26

                            God morgen. 🙂

                            1 Reply Last reply
                            0
                            • T Offline
                              T Offline
                              transalp
                              wrote on sidst redigeret af
                              #27

                              Go morgen.. 🙂

                              1 Reply Last reply
                              0
                              • royalR Offline
                                royalR Offline
                                royal
                                wrote on sidst redigeret af
                                #28

                                Hvor meget skal vi frygte Keytruda? http://investors.merck.com/news/press-release-details/2017/Merck-Announces-Second-Quarter-2017-Financial-Results/default.aspx

                                1 Reply Last reply
                                0
                                • bongobobB Offline
                                  bongobobB Offline
                                  bongobob
                                  wrote on sidst redigeret af
                                  #29

                                  Det skal vi ikke, se disse Interessante betragtninger af Dr. Philippe Moreau
                                  Meget stærkt signal når styrken af DRd kombi er et ”problem” http://www.bloodjournal.org/content/early/2017/07/26/blood-2017-05-743203

                                  1 Reply Last reply
                                  0
                                  • bongobobB Offline
                                    bongobobB Offline
                                    bongobob
                                    wrote on sidst redigeret af
                                    #30

                                    “a recurrent question is how to design a study to
                                    demonstrate the true impact of a specific agent on response, PFS or OS. For
                                    example, the HR value for PFS achieved with the DRd combination in relapsed MM
                                    in the POLLUX trial (0.37) has set the bar so high that it will be difficult to show the
                                    superiority of other combinations over DRd in phase 3 trials designed for regulatory
                                    approvals”

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #31

                                      Tak Bongo. 🙂

                                      1 Reply Last reply
                                      0
                                      • B Offline
                                        B Offline
                                        bibob
                                        wrote on sidst redigeret af
                                        #32

                                        God morgen. 🙂

                                        1 Reply Last reply
                                        0
                                        • B Offline
                                          B Offline
                                          bibob
                                          wrote on sidst redigeret af
                                          #33

                                          Meget fint link Bongo. Det bekræfter bare Dara's potientiale i combi. 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger